Cargando…
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925672/ https://www.ncbi.nlm.nih.gov/pubmed/33654067 http://dx.doi.org/10.1038/s41408-021-00443-1 |
| _version_ | 1783659321012256768 |
|---|---|
| author | Hampel, Paul J. Parikh, Sameer A. Call, Timothy G. Shah, Mithun V. Bennani, N. Nora Al-Kali, Aref Rabe, Kari G. Wang, Yucai Muchtar, Eli Leis, Jose F. Kenderian, Saad S. Koehler, Amber B. Schwager, Susan M. Slager, Susan L. Kay, Neil E. Hanson, Curtis A. Van Dyke, Daniel L. Shi, Min Ding, Wei |
| author_facet | Hampel, Paul J. Parikh, Sameer A. Call, Timothy G. Shah, Mithun V. Bennani, N. Nora Al-Kali, Aref Rabe, Kari G. Wang, Yucai Muchtar, Eli Leis, Jose F. Kenderian, Saad S. Koehler, Amber B. Schwager, Susan M. Slager, Susan L. Kay, Neil E. Hanson, Curtis A. Van Dyke, Daniel L. Shi, Min Ding, Wei |
| author_sort | Hampel, Paul J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7925672 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79256722021-03-19 Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia Hampel, Paul J. Parikh, Sameer A. Call, Timothy G. Shah, Mithun V. Bennani, N. Nora Al-Kali, Aref Rabe, Kari G. Wang, Yucai Muchtar, Eli Leis, Jose F. Kenderian, Saad S. Koehler, Amber B. Schwager, Susan M. Slager, Susan L. Kay, Neil E. Hanson, Curtis A. Van Dyke, Daniel L. Shi, Min Ding, Wei Blood Cancer J Correspondence Nature Publishing Group UK 2021-03-02 /pmc/articles/PMC7925672/ /pubmed/33654067 http://dx.doi.org/10.1038/s41408-021-00443-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Hampel, Paul J. Parikh, Sameer A. Call, Timothy G. Shah, Mithun V. Bennani, N. Nora Al-Kali, Aref Rabe, Kari G. Wang, Yucai Muchtar, Eli Leis, Jose F. Kenderian, Saad S. Koehler, Amber B. Schwager, Susan M. Slager, Susan L. Kay, Neil E. Hanson, Curtis A. Van Dyke, Daniel L. Shi, Min Ding, Wei Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title | Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_full | Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_fullStr | Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_full_unstemmed | Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_short | Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_sort | venetoclax treatment of patients with relapsed t-cell prolymphocytic leukemia |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925672/ https://www.ncbi.nlm.nih.gov/pubmed/33654067 http://dx.doi.org/10.1038/s41408-021-00443-1 |
| work_keys_str_mv | AT hampelpaulj venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT parikhsameera venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT calltimothyg venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT shahmithunv venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT bennaninnora venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT alkaliaref venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT rabekarig venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT wangyucai venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT muchtareli venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT leisjosef venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT kenderiansaads venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT koehleramberb venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT schwagersusanm venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT slagersusanl venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT kayneile venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT hansoncurtisa venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT vandykedaniell venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT shimin venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT dingwei venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia |